Spots Global Cancer Trial Database for A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer

Name: Albert C Koong, MD, PhD

Affiliation: Stanford University

Role: PRINCIPAL_INVESTIGATOR

Name: J. Marc Pipas, MD

Affiliation: Dartmouth-Hitchcock Medical Center

Role: PRINCIPAL_INVESTIGATOR

Name: Vincent J Picozzi, MD, PhD

Affiliation: Virginia Mason Hospital/Medical Center

Role: PRINCIPAL_INVESTIGATOR

Name: Peter J O'Dwyer, MD

Affiliation: University of Pennsylvania

Role: PRINCIPAL_INVESTIGATOR

Name: Smitha Krishnamurthi, MD

Affiliation: University Hospitals of Cleveland, Case Comprehensive Cancer Center

Role: PRINCIPAL_INVESTIGATOR

Name: Charles Lopez, MD

Affiliation: Oregon Health and Science University

Role: PRINCIPAL_INVESTIGATOR

Name: Nathan Bahary, MD

Affiliation: University of Pittsburgh

Role: PRINCIPAL_INVESTIGATOR